Cocrystal Pharma Inc.

NASDAQ: COCP · Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.72
1.11%
After-hours: Aug 15, 2025, 04:31 PM EDT

Cocrystal Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 144K 144K 144K 144K n/a n/a n/a n/a 5.43K 5.43K 5.43K 5.43K 510K 999K 1.55M
Cost of Revenue
61K 96K 140K 248K 316K 384K 553.6K 543.6K 537.6K 529.6K 527.5K 527.5K 527.5K 524.5K 523.9K 427.98K 334.95K
Gross Profit
-33K -68K 4K -104K -172K -240K -553.6K -543.6K -537.6K -529.6K -522.07K -522.07K -522.07K -519.07K -13.9K 571.02K 1.22M
Operating Income
-16.06M -17.88M -20.31M -19.71M -18.61M -19.56M -18.39M -19.65M -39.73M -38.83M -38.03M -36.29M -15.69M -14.22M -11.98M -10.74M -10.36M
Interest Income
n/a n/a 180K 500K 640K 640K 460K 140K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-15.85M -17.5M -18.7M -17.93M -16.75M -17.98M -18.02M -19.56M -39.82M -38.84M -38.02M -36.26M -15.65M -14.19M -11.99M -10.72M -10.4M
Net Income
-15.85M -17.5M -18.7M -17.93M -16.75M -18.06M -18.1M -19.64M -60.6M -59.54M -58.72M -56.96M -15.66M -14.19M -11.99M -10.72M -10.4M
Selling & General & Admin
5.11M 5.31M 5.51M 5.56M 5.96M 5.99M 5.81M 5.78M 5.62M 5.75M 5.93M 5.89M 5.6M 5.43M 5.04M 4.37M 5.32M
Research & Development
10.95M 12.54M 14.77M 15.72M 14.21M 15.17M 14.19M 13.87M 13.43M 12.39M 11.41M 9.7M 10.09M 8.79M 7.46M 7.37M 6.6M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a 20.69M 20.69M 20.69M 20.69M n/a n/a n/a n/a n/a
Operating Expenses
16.03M 17.82M 20.28M 21.28M 20.17M 21.16M 20M 19.65M 19.04M 18.14M 17.34M 15.6M 15.69M 14.22M 12.49M 11.74M 11.92M
Interest Expense
37K 220K 220K 540K 680K 538K 539K 220K 80K 3K 2K 2K 4K 4K 6K 7K 7K
Selling & Marketing Expenses
n/a -35K -35K -35K -35K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
13.82M 17.98M 20.31M 21.32M 20.21M 21.16M 20M 19.65M 19.04M 18.14M 17.34M 15.6M 15.69M 14.22M 12.49M 11.74M 11.92M
Income Tax Expense
n/a n/a -30.48K -30.48K -30.48K 47.52K 80K 86K 20.78M 20.7M 20.7M 20.7M 5.99K 3.99K 6K 7K 7K
Shares Outstanding (Basic)
10.17M 10.17M 10.17M 10.17M 10.17M 10.17M 10.15M 10.06M 8.14M 8.14M 8.14M 8.12M 8.12M 7.26M 8.12M 7.26M 5.94M
Shares Outstanding (Diluted)
10.17M 10.17M 10.17M 10.17M 10.17M 10.17M 10.15M 10.06M 8.14M 8.14M 8.14M 8.12M 8.12M 7.26M 8.14M 7.26M 5.94M
EPS (Basic)
-1.57 -1.73 -1.85 -1.77 -1.65 -1.91 -2.02 -2.31 -7.45 -7.32 -7.28 -7.07 -2.05 -1.99 -1.79 -1.86 -2.13
EPS (Diluted)
-1.57 -1.73 -1.85 -1.77 -1.65 -1.91 -2.02 -2.31 -7.45 -7.32 -7.28 -7.06 -2.04 -1.98 -1.78 -1.86 -2.13
EBITDA
-15.83M -17.61M -18.95M -19.99M -18.92M -19.86M -19.79M -19.4M -18.75M -17.8M -16.99M -15.23M -15.27M -13.85M -11.68M -10.46M -10.19M
EBIT
-13.76M -17.91M -20.31M -21.32M -20.21M -21.16M -19.99M -19.64M -19.04M -18.14M -17.32M -15.57M -15.65M -14.18M -11.99M -10.71M -10.39M
Depreciation & Amortization
233K 268K -1.53M -1.52M -1.46M -1.39M 412K 402K 396K 388K 385K 385K 385K 382K 330K 276K 219K